Efficacy & Safety of Anticoagulants in Cirrhosis HCC

Status:
RECRUITING

Trial end date:
2025-08-01

Target enrollment:

Participant gender:

We will give an anticoagulant against portal vein thrombosis, and watch for the results.

PHASE4

Mansoura University

apixaban
Enoxaparin